K M Munir1, D C French, L A Loeb
1Joseph Gottstein Memorial Cancer Research Laboratory, Department of Pathology, University of Washington, Seattle 98195.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers engineered herpes simplex virus type 1 thymidine kinase mutants with altered catalytic properties and enhanced stability. This method uses random mutagenesis and genetic selection to create novel enzymes for potential gene therapy applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: